Shanghai Realbio Technology Co., Ltd was founded in 2014, headquartered in the Pujiang High-tech Park, Minhang District, Shanghai,China. It is a national high-tech enterprise specializing in early accurate tumor detection. Regional centers have been established in Hangzhou, Qingdao, and other cities. The company operates independent medical testing laboratories in both Shanghai and Qingdao. Meanwhile, GMP-standard production workshops which cover an area of approximately 3000 square meters have been established in both Shanghai and Hunan.

With its core technology advantages in genetic testing, Realbio is dedicated to the development of multiple early non-invasive tumor detection products. It aims to achieve early cancer detection that is ultra-early, precise, safe, and highly compliant. By helping early-stage cancer patients seize the "golden window of opportunity" for clinical intervention, and by providing comprehensive automation of the testing process, it offers robust support for large-scale tumor testing and enables the digital upgrade of the IVD industries. Realbio has become a true leader in accurate tumor detection in China.

• Hangzhou Realbio Bioinformatics Analysis Center
• Hunan Realbio GMP standard production workshop

• Hangzhou Realbio Bioinformatics Analysis Center is situated within the Xihu Science and Technology Park in Hangzhou, Zhejiang Province, China. It serves as the research and development hub carefully established by Real Biotech Group. The company boasts advanced experimental equipment and a robust bioinformatics analysis platform. The laboratory is fully equipped with facilities such as a biosafety cabinet II, Agilent 2100 detection equipment, Qubit fluorometer, NanoDrop microvolume spectrophotometer, fluorescence quantitative PCR instrument, electrophoresis apparatus, large-scale high-speed centrifuge, gel imaging device, etc.

  
  

  In terms of information analysis platform construction, Hangzhou Bioinformatics Center has implemented a high-performance computing cluster system, aiming to provide comprehensive solutions and technical support for various clinical research initiatives at the headquarters. The center is equipped with a big data analysis platform, achieving a computational power of 50T flops and storage capacity exceeding 2PB. Furthermore, it has collaborated with Alibaba Cloud to establish a more robust computing platform in the cloud, capable of supporting the research of big data algorithms and systems designed for PB-level genomic data.

  
  

  Hangzhou Realbio occupies a crucial strategic position in research and development. This includes collecting and investigating industry-leading information to analyze products with potential for approval from a technical perspective. Subsequently, it involves formulating research and development plans, as well as implementing concrete implementation strategies and carrying out experiments to efficiently advance product finalization and successful outcomes.

• Realbio Technology Hunan Branch was established in 2021. It has established a 1,200 square meter clean production workshop that meets GMP standards, with grades of ten thousand and one hundred thousand. Additionally, it has implemented a quality management system in accordance with ISO 13485. The branch possesses full-process research and development, production, and inspection capabilities for IVD reagents and medical device software (including other active medical device products), and is equipped with corresponding equipment and facilities. It has the ability to produce in vitro diagnostic reagents with reliable quality, strong stability, and high safety, as well as efficient supply. The establishment and development of Realbio Technology Hunan Branch have accelerated the company's digitized, scaled, and intelligent production of medical devices.